2012 Confirmed Speakers & Attendees:

• Senior Director, Business Development, Trius Therapeutics
• President and CEO, Agile Therapeutics
• Technology Marketing Manager, University of Minnesota
• Vice President of Worldwide Business Development, Pfizer
• Vice President of Business Development & Licensing, Covidien
• SVP of Business and Commercial Development & Chief Business Officer, Targacept, Inc.
• Director of Business Development, Envoy Therapeutics
• VP Business Development, Supernus Pharmaceuticals Inc.
• Vice President Business Development & Licensing, Supernus Pharmaceuticals Inc.
• SVP Business Planning, Amicus Therapeutics
• Senior Director of Business Development, BTG International Inc.
• Director of Business Development, Teva Canada
• Sr. Vice President, Chief Business Officer, NextWave Pharmaceuticals
• Chair Licensing & Strategic Alliances Practice Group, Foley Hoag
• Senior Director of Business Development, Noven Pharmaceuticals
• CFO, Bionovo Inc
• Vice President, Corporate Development, Genzyme
• Managing Director, APEX Healthcare Consulting Ltd
• Executive Manager: Commercial, CSIRO
• Chief Executive Officer, Keystone Nano
• VP Business Development, Reata Pharmaceuticals, Inc.
• Ailliance Director, Eli Lilly and Company
• Vice President of Global New Deal Strategy & Development, ceedd, GSK
• Senior Executive Director Licensing and Business Development, Purdue Pharma L.P.
• SVP Corporate Development, Acceleron Pharma Inc
• Principal, Research Analyst, Life Sciences, Canaccord Genuity Inc
• Vice President of Intellectual Property, Shire Pharmaceuticals
• Vice President of Licensing and Intellectual Property, Targacept, Inc.
• Vice President Corporate Strategy, Cornerstone Therapeutics Inc.
• Vice President of Business Development, Noven Pharmaceuticals
• Business Development Director for Latin American Region, AstraZeneca
• Senior Director, Business Development & New Product Planning, MannKind Corporation
• President and CEO, Altiris Therapeutics
• Director of Business Development & Partnering, UCB Pharma, Inc.
• Head of BI Partnering, Boehringer-Ingelheim Pharmaceuticals Inc.
• Director of Business Development, AstraZeneca
• Vice President of Strategy and Operations, Enlight Biosciences
• Vice President of Business Development, Sun Pharmaceuticals Industries Inc
• Senior Manager, BD&L, Covidien
• Head of Business Development, Bayer
• Principal, Geisinger Ventures
• COO & CFO, Meda Pharmaceuticals
• Vice President of Business Development for Dosage Pharmaceuticals, Covidien
• Vice President, Business Development, Evotec
• Senior Vice President of Business Development, Transtech Pharma, Inc.
• Patent Attorney, Finnegan, Henderson, Farabow, Garret & Dunner L.L.P.
• Director, Industry Alliances, QB3
• Vice President, Business Development and Strategic Planning, Ligand Pharmaceuticals, Inc.
• Director of Finance and Operations, ZymeworksInc.
• Business Development Manager, Deloitte Recap LLC
• Executive Director, Business Development, Bristol-Myers Squibb Company
• Director of Business Development, Nektar Therapeutics
• VP Pharmaceutical R&D, MannKind Corporation
• Manager, Elusys Therapeutics, Inc.
• Director, Office of Tech Mgmt., University of Pittsburgh Office of Technology Management
• Senior Director of Industry Relations, Upsher-Smith Laboratories Inc
• Senior Vice President of Research, Furiex Pharmaceuticals
• Partner, Sofinnova Ventures
• Senior Vice President, Business Development, Shire Pharmaceuticals
• Senior Staff Scientist, Bayer Healthcare
• Vice President of Corporate Development & Legal Affairs, XDx, Inc.
• Head of Business and Corporate Development, Concert Pharmaceuticals, Inc.
• Director Business Development, Forest Laboratories, Inc.
• Manager, Sales & Solutions, EvaluatePharma Inc
• Director, Worldwide Licensing, Merck & Co., Inc.
• Vice President of Corporate Development and Legal Affairs, VLST Corporation
• President and CEO, NPS Pharmaceuticals Inc.
• Manager, Sanofi-Aventis
• Manager, Sales and Solutions, EvaluatePharma Inc
• Senior Associate, Genzyme Ventures
• President CEO & Director, Elusys Therapeutics, Inc.
• Director Business Development, Aptalis Pharmaceutical Technologies
• VP Marketing & Business Development, Meda Pharmaceuticals
• VP & General Manager US Operations, Biocodex Inc.
• VP Biological Development(in GUD) spoke at conference, Bayer Healthcare Pharmaceuticals
• Director Business Development, Rexahn Pharmaceuticals Inc.
• CEO, NextWave Pharmaceuticals
• President & CEO, Ade Therapeutics
• Director, Business Development, Isis Pharmaceuticals, Inc.
• Principal Intellectual Property Counsel, Medicis Pharmaceutical Corporation
• Sr. Director, Device Design, MannKind Corporation
• Vice President of Business Development, Array Biopharma Inc.
• Director-Licensing, External R&D, Amgen Limited
• Principle Business Development & Strategy, Biocodex Inc.
• Vice President, Business Development, Biogen Inc.
• Principal, Commercial Healthcare Partners, LLC
• Director, Venture Investments, Abbott Ventures
• Director, H.I.G Ventures
• Senior Vice President of Business Development and Strategy, Nycomed US
• Vice President and Global Head of Strategic Alliances, Novartis Institutes for BioMedical Research Inc
• Director, Worldwide Licensing & External Research, Merck